Activation of the endocannabinoid system by organophosphorus nerve agents
- 27 April 2008
- journal article
- research article
- Published by Springer Science and Business Media LLC in Nature Chemical Biology
- Vol. 4 (6), 373-378
- https://doi.org/10.1038/nchembio.86
Abstract
Δ9-Tetrahydrocannabinol (THC), the psychoactive ingredient of marijuana, has useful medicinal properties but also undesirable side effects. The brain receptor for THC, CB1, is also activated by the endogenous cannabinoids anandamide and 2-arachidonylglycerol (2-AG). Augmentation of endocannabinoid signaling by blockade of their metabolism may offer a more selective pharmacological approach compared with CB1 agonists. Consistent with this premise, inhibitors of the anandamide-degrading enzyme fatty acid amide hydrolase (FAAH) produce analgesic and anxiolytic effects without cognitive defects. In contrast, we show that dual blockade of the endocannabinoid-degrading enzymes monoacylglycerol lipase (MAGL) and FAAH by selected organophosphorus agents leads to greater than ten-fold elevations in brain levels of both 2-AG and anandamide and to robust CB1-dependent behavioral effects that mirror those observed with CB1 agonists. Arachidonic acid levels are decreased by the organophosphorus agents in amounts equivalent to elevations in 2-AG, which indicates that endocannabinoid and eicosanoid signaling pathways may be coordinately regulated in the brain.Keywords
This publication has 43 references indexed in Scilit:
- Dual roles of brain serine hydrolase KIAA1363 in ether lipid metabolism and organophosphate detoxificationToxicology and Applied Pharmacology, 2008
- The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: Δ9‐tetrahydrocannabinol, cannabidiol and Δ9‐tetrahydrocannabivarinBritish Journal of Pharmacology, 2008
- A Comprehensive Profile of Brain Enzymes that Hydrolyze the Endocannabinoid 2-ArachidonoylglycerolCell Chemical Biology, 2007
- Cannabinoids mediate analgesia largely via peripheral type 1 cannabinoid receptors in nociceptorsNature Neuroscience, 2007
- The endocannabinoid system in targeting inflammatory neurodegenerative diseasesTrends in Pharmacological Sciences, 2007
- The Endocannabinoid System Controls Key Epileptogenic Circuits in the HippocampusNeuron, 2006
- Inverse agonism and neutral antagonism at cannabinoid CB1 receptorsLife Sciences, 2005
- Organophosphate Toxicology: Safety Aspects of Nonacetylcholinesterase Secondary TargetsChemical Research in Toxicology, 2004
- Discovering potent and selective reversible inhibitors of enzymes in complex proteomesNature Biotechnology, 2003
- Subacute Neurotoxicity Induced in Mice by Potent Organophosphorus Neuropathy Target Esterase InhibitorsToxicology and Applied Pharmacology, 1996